Validation of electronic data on chemotherapy and hormone therapy use in HMOs. - Wikidata - wikimedia - TriplyDB

Validation of electronic data on chemotherapy and hormone therapy use in HMOs.

Validation of electronic data on chemotherapy and hormone therapy use in HMOs.

http://www.wikidata.org/entity/Q34244526

about

Sustaining Research Networks: the Twenty-Year Experience of the HMO Research Network Comparison of SEER Treatment Data With Medicare Claims.Detecting Lung and Colorectal Cancer Recurrence Using Structured Clinical/Administrative Data to Enable Outcomes Research and Population Health Management.Predicting neutropenia risk in patients with cancer using electronic data.Advanced imaging among health maintenance organization enrollees with cancer Treatment patterns for ductal carcinoma in situ from 2000-2010 across six integrated health plans Use of Bevacizumab in Community Settings: Toxicity Profile and Risk of Hospitalization in Patients With Advanced Non-Small-Cell Lung Cancer Patterns and predictors of first-line chemotherapy use among adults with advanced non-small cell lung cancer in the cancer research network.Validating billing/encounter codes as indicators of lung, colorectal, breast, and prostate cancer recurrence using 2 large contemporary cohorts Developing an Algorithm to Identify History of Cancer Using Electronic Medical Records.Comparative effectiveness of adjunctive bevacizumab for advanced lung cancer: the cancer research network experience Comparing cancer care, outcomes, and costs across health systems: charting the course.Diffusion of Intraperitoneal Chemotherapy in Women with Advanced Ovarian Cancer in Community Settings 2003-2008: The Effect of the NCI Clinical Recommendation Cancer research network: using integrated healthcare delivery systems as platforms for cancer survivorship research.Identifying cancer drug regimens in French health insurance database: An application in multiple myeloma patients.Optimizing patient-reported outcome and risk factor reporting from cancer survivors: a randomized trial of four different survey methods among colorectal cancer survivors.Effect of Angiotensin System Inhibitors on Survival in Patients Receiving Chemotherapy for Advanced Non-Small-Cell Lung Cancer.Survival after recurrence of stage I-III breast, colorectal, or lung cancer.Risk of Breast Cancer With Long-Term Use of Calcium Channel Blockers or Angiotensin-Converting Enzyme Inhibitors Among Older Women.

P2860

Q28651796-D14EF54C-C5E4-49FE-9172-1049489BF0F4 Q30779910-61745B3A-6DEE-4ADE-A8B4-E34536AD2B93 Q30983918-36225167-3AC5-4DF8-986E-D572C673E371 Q31131362-D0706903-EDC2-412E-8DD6-613F65446705 Q33890471-268B4C76-F518-4CE0-AB1A-5BCE2C40E17F Q34989912-D16223D0-E155-4104-8C73-A225405F8190 Q36073707-039C1F08-E9ED-463D-BE0E-583424F60E7D Q36374254-4427EF1E-AB65-401C-8F7C-448BF4FE8A1C Q36692575-91B3ECB9-85D1-42A4-9CFF-63DDD4C4219C Q36888689-8DEF8742-B87E-424C-8966-6E52040970B1 Q37372172-68DA1E0F-DD6C-42DB-9091-86683ABE17CB Q37383675-8B0FA4DD-00EB-484B-8E84-44C43CD5AE03 Q37627681-8CFEE2FD-EBFC-426D-9E55-EE7D0E544928 Q38067315-D892B2B0-4F1E-410C-BEF8-9548B1C606A0 Q38660850-00DA8B38-D5BC-460E-B1DF-8E0A1BD5A999 Q38770893-F0E902BC-9463-4EC4-AE39-4A518C1B781D Q46018831-4E5EE1F7-F5D7-47A5-8C19-A19793B23B9F Q50528546-8BC29ED8-5CBB-4D54-88A5-7C86254227B0 Q50899870-7EF32E28-65C1-4C08-8F7F-720529C57B16

P2860

Validation of electronic data on chemotherapy and hormone therapy use in HMOs.

http://www.wikidata.org/entity/Q34244526

description

2013 nî lūn-bûn

@nan

2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Validation of electronic data on chemotherapy and hormone therapy use in HMOs.

@ast

Validation of electronic data on chemotherapy and hormone therapy use in HMOs.

@en

Validation of electronic data on chemotherapy and hormone therapy use in HMOs.

@nl

type

label

Validation of electronic data on chemotherapy and hormone therapy use in HMOs.

@ast

Validation of electronic data on chemotherapy and hormone therapy use in HMOs.

@en

Validation of electronic data on chemotherapy and hormone therapy use in HMOs.

@nl

prefLabel

Validation of electronic data on chemotherapy and hormone therapy use in HMOs.

@ast

Validation of electronic data on chemotherapy and hormone therapy use in HMOs.

@en

Validation of electronic data on chemotherapy and hormone therapy use in HMOs.

@nl

P1433

Q34244526-BEB951C2-32A7-4F39-8925-3212BDC34D4E

P1476

Q34244526-657FD7CD-15CE-4EA1-83B0-E1D03587748E

P2093

Q34244526-0B377C5F-5322-4E6F-ACB1-F9641A2FBAEC

Q34244526-15B6F060-6C25-445D-90C6-C9FB4C5C99CA

Q34244526-23C89B8E-CCCE-42E7-AF64-BEB64B9DCE54

Q34244526-3948A8BE-49D0-4533-B9CD-442E2D64503E

Q34244526-53D41CEF-F29B-4AFD-B002-5B4D9219454F

Q34244526-6450C74C-A7CE-4FDB-9330-263E540E89A3

Q34244526-69FE7AC2-A58E-43BD-9D74-A8039D971F69

Q34244526-8A168BD7-06CF-4E84-A5C7-567DF62A6FB2

Q34244526-DEC4DBE5-39DC-413C-8307-FB901399B090

P2860

Q34244526-0580DB09-7E0E-41C2-807F-40A992EEB5FD

Q34244526-1C17E3EA-C3B3-4F8A-8B2E-8A88D8A31B7D

Q34244526-30B5B8DB-C495-467E-8A48-F212DE020ECC

Q34244526-43E3AE15-4585-487D-9C3F-2F2052ED51A6

Q34244526-5323AB62-5129-4EB0-B3E7-CE4418981FB0

Q34244526-69091C52-B217-4581-AEE5-44970A01E269

Q34244526-6DBF4FBF-B1E8-4BF8-99B4-FADD3841223C

Q34244526-82B47419-3453-4909-90C0-8512A8669030

Q34244526-8A7682B9-4661-4822-8A52-60BAD6BBD610

Q34244526-9812A0DD-B265-4495-9F05-EA8387E309A8

P304

Q34244526-248991DA-9669-48EE-95CD-961206821825

P31

Q34244526-862AA16A-576D-4310-AEC0-CFC33B31120B

P356

Q34244526-28CE36A1-5D8F-4193-B00D-214CA968BD34

P433

Q34244526-D8EBE982-0746-468D-B3C5-1EE3DFDF0403

P478

Q34244526-D996B497-3DEB-44D9-9E95-5CD650B258E9

P577

Q34244526-523D3C4C-12F5-4FA8-990A-B87C80B6F517

P698

Q34244526-C5CF413E-FC20-4A8B-B0C4-35E44DFD9A83

P921

Q34244526-30A2F70E-A495-4995-AD87-2A720604D6EE

P932

Q34244526-EC262C63-7CF3-461E-9E4B-A13CA1ED6AFC

P356

MLR.0B013E31824DEF85

P1433

P1476

Validation of electronic data on chemotherapy and hormone therapy use in HMOs.

@en

P2093

Debra P Ritzwoller

http://www.w3.org/2001/XMLSchema#string

Elizabeth T Loggers

http://www.w3.org/2001/XMLSchema#string

Erin J Aiello Bowles

http://www.w3.org/2001/XMLSchema#string

Jennifer Elston-Lafata

http://www.w3.org/2001/XMLSchema#string

Mark C Hornbrook

http://www.w3.org/2001/XMLSchema#string

Maureen O'Keeffe-Rossetti

http://www.w3.org/2001/XMLSchema#string

Nikki Carroll

http://www.w3.org/2001/XMLSchema#string

Paul A Fishman

http://www.w3.org/2001/XMLSchema#string

Thomas Delate

http://www.w3.org/2001/XMLSchema#string

P2860

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population.

Utility of the SEER-Medicare data to identify chemotherapy use.

Identifying cancer relapse using SEER-Medicare data.

Accuracy and complexities of using automated clinical data for capturing chemotherapy administrations: implications for future research

Preliminary report: the development of the NCCN Comparative Therapeutic Index™ as a clinical evaluative process for existing data in oncology.

Construct validity of medicare chemotherapy claims: the case of 5FU.

Age, comorbidity, and breast cancer severity: impact on receipt of definitive local therapy and rate of recurrence among older women with early-stage breast cancer

Criterion validity of Medicare chemotherapy claims in Cancer and Leukemia Group B breast and lung cancer trial participants.

P304

e67-73

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MLR.0B013E31824DEF85

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P577

2013-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22531648

http://www.w3.org/2001/XMLSchema#string

P921

P932

3406224

http://www.w3.org/2001/XMLSchema#string